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The unnecessary treatment of diabetes with insulin has been recognised increasingly.' Large doses of insulin may be well tolerated without appreciable hypoglycaemia, for which several mechanisms have been postulated. The development of insulin antibodies may effectively neutralise exogenous insulin, and we describe a diabetic patient treated unnecessarily with insulin in whom this mechanism may have prevented hypoglycaemia.
Case report
In 1927 a 19 year old clerk presented with glycosuria and a history of thirst, polyuria, and weight loss. Diabetes mellitus was diagnosed. There was no family history of diabetes. He was treated with soluble and protamine zinc insulin and subsequently changed to 40 units lente insulin daily. Frequent analysis of urine showed good control.
In 1976 he attended with minor sepsis, and a random blood glucose estimation gave a value of 17-3 mmol/l (312 mg/100 ml). He continued with daily lente insulin, and postprandial glucose values varied from 4-3 to 5-1 mmol/l (77 to 92 mg/100 ml). He had no clinical or biochemical evidence of nephropathy or neuropathy and had minimal background retinopathy with a few scattered microaneurysms and an occasional dot haemorrhage. In 1978 he was awarded the Joslin Gold Medal in recognition of his successful treatment with insulin for more than 50 years. In 1979 a random plasma C-peptide estimation with antibody M12302 showed an unexpected value of 2-5 nmol/l (7-6 ng/ml), which suggested that he had residual beta cell function. Over the next two months his dose of lente insulin was reduced from 40 to 16 units daily. He remained asymptomatic with no ketonuria and blood glucose values of 4-6-5-4 mmol/l (83-97 mg/100 ml). A glucagon stimulation test (1 mg intravenously) was performed to assess pancreatic and beta cell function and plasma C-peptide values measured before (total C-peptide) and after removal of insulin antibodies from the plasma by acid extraction (free C-peptide). The results (basal C-peptide values: total 0-86 nmol/l (2-6 ng/ml), free 0-64 nmol/l (1-9 ng/ml); 20 minutes after glucagon: total 0-96 nmol/l (2-9 ng/ml), free 0-72 nmol/l (2-2 ng/ml)) confirmed preservation of significant endogenous insulin secretion. One month after withdrawal of insulin an oral glucose tolerance test (50 g) confirmed impaired glucose tolerance ( 
Comment
It is apparent in retrospect that this man developed the non-insulin dependent type of diabetes, sometimes known as maturity onset diabetes of youth. In 1927, however, it was assumed that he was insulin dependent, and this would never have been reviewed but for the fortuitous measurement of the plasma C-peptide concentration, which showed underlying pancreatic beta cell function. Surprisingly he had never had hypoglycaemia; this may be explained by neutralisation of the hypoglycaemic effect of exogenous insulin by the Potential hazard of nebulised salbutamol in patients with haemoptysis
Mild haemoptysis is fairly common in bronchiectasis but severe haemoptysis is rare and may be due to hypertrophy of the bronchial arteries, and hence bleeding may occur from the systemic circulation.' Selective adrenoceptor agonists such as salbutamol and terbutaline are commonly used as bronchodilators. These drugs, as well as relaxing smooth muscle in the bronchial wall, result in systemic and pulmonary vascular vasodilatation if given intravenously or by mouth.23 We describe a patient with bronchiectasis in whom nebulised salbutamol apparently increased the degree of haemoptysis. 
